Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Am J Transplant. 2021 Feb 9;21(7):2468–2478. doi: 10.1111/ajt.16466

Figure 3:

Figure 3:

The survival benefit associated with SHK is inversely proportional to pre-transplant eGFR. Overall patient survival among non-DD patients is plot stratified by eGFR with all patients with an eGFR 0–20 (a), >20–30 (b), >30–40 (c), >40–50 (d), and >50–100 mL/min/1.73m2 (e) plotted.